AVY

Analyst Note: AVY (Avery Dennison Corporation)

Date: 2026-06-13 Current Price: $158.68

1. Structural Readiness

State: Context-Only Conservative Entry: — Breakout Level: — Extension: — ATR Current: 2.5% (Productive)

2. Thesis Layer

Thesis Status: Tactical / Setup-Led Macro Thesis: None Named.

At this date, AVY is not anchored to a specific named secular macro thesis (e.g., "AI Infrastructure," "Green Energy Transition"). The investment case is strictly TACTICAL, driven by the quality of the structural setup and the immediate business fundamentals. The conviction must be derived from the company's ability to execute its guidance and the technical resolution of the current forming coil, rather than a broad thematic tailwind.

3. Business Overview

Avery Dennison Corporation is a global enterprise specializing in the manufacturing and distribution of innovative pressure-sensitive materials and related product solutions. The company operates through two primary reportable segments:

• Materials Group (approx. 69% of sales): A leading global provider to the pressure-sensitive label and graphics industries. Key brands include Fasson, JAC, and Mactac. This segment serves industries including home and personal care, food and beverage, automotive, and construction.
• Solutions Group (approx. 31% of sales): A leading provider of information and branding solutions, including RFID products, retail media, and compliance tools.

Operational Context (as of Q1 2026 / FY2025):

• Geographic Mix: International operations are substantial, generating approximately 69% of net sales in Q1 2026, with emerging markets accounting for roughly 40% of total sales in 2025.
• Recent M&A: In 2025, the company acquired W.F. Taylor Holdings, Inc. ("Taylor Adhesives") for approximately $390 million to expand its flooring adhesives business.
• Strategic Investment: Management recently signed an agreement to invest an incremental $75 million in Williard to strengthen the enterprise-wide Intelligent Labels platform.
• Customer Base: Serves a diverse array of industries including apparel, general retail, e-commerce, logistics, food and grocery, pharmaceuticals, and automotive.

4. Archetype and Conviction

Archetype: Quality Compounder Rationale: The company fits the "Quality Compounder" archetype based on its consistent dividend growth, strategic reinvestment in high-value categories (Intelligent Labels), and ability to navigate inflationary environments through pricing power.

Fundamental Evidence (Management Expectations):

• Growth Guidance: Management anticipates earnings growth at the midpoint of their guidance range with organic sales growth of 0% to 2% for the period.
• Category Recovery: Management expects "high value categories" to return to growth as the year progresses. Specifically, in the largest category (apparel and general retail), sales were up low single digits despite a difficult pre-tariff comparison.
• Inflation & Pricing: Management anticipates high single-digit sequential inflation in Q2 2026, which typically supports pricing power in this sector.
• Cost & Efficiency: The company reported incremental savings from restructuring actions of more than $60 million in 2025. Management expects these savings, net of transition costs, to continue impacting operating income.
• Dividend: In April 2026, the company increased its quarterly dividend rate to $1.00 per share (a ~6% increase), signaling confidence in cash flow generation.
• Tax & FX: Management expects a full-year effective tax rate in the high-twenty percent range and noted a favorable impact from foreign currency translation on full-year net sales and operating income.

Valuation & Financial Spine:

• Forward consensus EPS for FY1 is $10.03 and FY2 is $11.12.
• The ATR of 2.5% is currently "productive" but below the 4–6% historical sweet spot for aggressive breakout setups. This suggests the market is currently pricing in a steady, low-volatility environment rather than a high-growth surprise.

Conviction Stack:

• Thesis Strength: Low (Tactical only).
• Evidence Quality: High (Clear guidance, recent dividend hike, specific M&A integration).
• Structural Quality: Moderate (Forming coil, awaiting breakout).
• Rerating Potential: Dependent on the "high value categories" returning to growth as management expects and the successful scaling of the Intelligent Labels platform in the second half of the year.

5. Invalidations, Strengths, and Gaps

What Would Strengthen the Case:

• Volume Recovery: Confirmation that the volume unwind mentioned in Q2 is complete and volume growth accelerates in the second half of the year.
• Margin Expansion: Evidence that the "high single-digit inflation" translates into operating margin expansion rather than just top-line revenue.

What Would Invalidate the Case:

• Guidance Miss: A failure to deliver the "midpoint of guidance" earnings growth or a reduction in the organic sales growth outlook (currently 0-2%).
• Tariff Impact: A material acceleration in tariff-related headwinds that exceeds the "pre-tariff comparison" hurdles already noted.

Evidence Gaps:

• Q2 Volume Unwind Details: While management expects the volume to "largely unwind" in the second half of Q2, the specific magnitude of this impact is not quantified in the provided evidence.
• Taylor Adhesives Integration: While the acquisition is noted, specific synergy realization metrics for the $390M deal are not detailed in the current evidence set.

PRIVATE ANALYST CALL

Judgment: Hold Confidence: medium Key evidence: Management guidance for organic sales growth of 0-2% and earnings at midpoint; recent 6% dividend increase to $1.00; forming coil structure with price above implied support. Sizing hint: Position size should be conservative until the forming coil resolves into a confirmed breakout; current setup is a watch-list candidate, not a trigger. Expected path: Management expects high-value categories to return to growth and volume to unwind in H2; Intelligent Labels programs to scale in the second half of the year. Expected horizon: 3 to 6 months for the forming coil to resolve into a confirmed breakout or invalidation.